Global Strategy > Case History > Corporate Finance e M&A > Company operating in the production of injectable pharmaceuticals
Corporate Finance e M&A

Company operating in the production of injectable pharmaceuticals

Business Area
Corporate Finance e M&A
  • The Company, founded in the 1920s, is one of the main producers of generic injectable drugs both for third parties and under its own brand
  • The product range is attributable to the sale of medicinal products (such as antibiotics, antidotes and anti-inflammatories), supplements for food diets and medical devices. About 80% is produced abroad
  • A few years ago, a Private Equity fund took over the 100% of the Company’s capital from the owners

Objectives

  • Business Due Diligence for the Private Equity fund as part of the acquisition process of the Company

Our Work

  • Analysis of the economic, operating and financial results relating to the 5 years preceding the Project and identification of the critical areas
  • Evaluation and analysis of markets, products, customers, industrial processes and organizational structure
  • Verification of the consistency of the business model with the current performance and conditions of the markets in which the Company operates, through sector and market research, interviews with industry experts and management
  • Analysis of the Business Plan and specific risks related to the business

Key financials

(euro mln; #)
Key FinancialsYear
2013		Year
2014		Year
2015		Year
2016		Year
2017
Operating Revenues2728272916
Ebitda2,03,02,30,70,6
NFP66689
# Employees~80~80~90~90~100
Find out our services
and let's plan a meeting
Contact Us